|Bid||10.73 x 3000|
|Ask||10.74 x 3000|
|Day's range||10.57 - 10.81|
|52-week range||10.08 - 16.60|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||16.08|
|Forward dividend & yield||1.20 (9.01%)|
|Ex-dividend date||10 Feb 2023|
|1y target est||N/A|
IRVINE, Calif., February 21, 2023--Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2022.
IRVINE, Calif., February 14, 2023--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, will present at the WISE Forum, and other members of the company will attend the WISE Forum on February 28, 2023, at the Rancho Valencia Resort and Spa in Rancho Santa Fe, California.
IRVINE, Calif., February 02, 2023--Sabra Health Care REIT, Inc. ("Sabra", "the Company") (Nasdaq: SBRA) announced today that since September 30, 2022, the Company has received roughly $185 million of gross proceeds related to previously disclosed disposition activity. In addition, the 24 properties formerly leased to North American ("North American") have been successfully transitioned to Ensign ("Ensign") (Nasdaq: ENSG) and the Avamere Family of Companies ("Avamere").